Allmed Medical Products Co Ltd Class A (002950) — Working Capital to Net Assets Ratio
Allmed Medical Products Co Ltd Class A (002950) has a Working Capital to Net Assets ratio of 28.8% as of March 2026. Working capital of CN¥1.07 Billion (current assets of CN¥2.34 Billion minus current liabilities of CN¥1.27 Billion) is measured against net assets of CN¥3.72 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 002950 equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Allmed Medical Products Co Ltd Class A Working Capital to Net Assets (2014–2025)
This chart shows how Allmed Medical Products Co Ltd Class A's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 28.8%, reflecting working capital of CN¥1.07 Billion against net assets of CN¥3.72 Billion CNY. Check Allmed Medical Products Co Ltd Class A (002950) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Allmed Medical Products Co Ltd Class A (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Allmed Medical Products Co Ltd Class A from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 002950 market cap overview.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 29.8% | CN¥1.08 Billion | CN¥3.61 Billion | CN¥2.40 Billion | CN¥1.33 Billion | ▲ +6.0 pp |
| 2024 | 23.8% | CN¥820.08 Million | CN¥3.45 Billion | CN¥1.93 Billion | CN¥1.11 Billion | ▲ +9.6 pp |
| 2023 | 14.1% | CN¥454.08 Million | CN¥3.21 Billion | CN¥1.78 Billion | CN¥1.33 Billion | ▲ +3.5 pp |
| 2022 | 10.6% | CN¥332.03 Million | CN¥3.13 Billion | CN¥2.40 Billion | CN¥2.07 Billion | ▼ -11.4 pp |
| 2021 | 22.0% | CN¥604.51 Million | CN¥2.75 Billion | CN¥2.24 Billion | CN¥1.64 Billion | ▼ -24.9 pp |
| 2020 | 46.9% | CN¥1.37 Billion | CN¥2.92 Billion | CN¥2.84 Billion | CN¥1.47 Billion | ▼ -3.7 pp |
| 2019 | 50.6% | CN¥1.04 Billion | CN¥2.06 Billion | CN¥1.66 Billion | CN¥620.38 Million | ▲ +25.2 pp |
| 2018 | 25.4% | CN¥336.25 Million | CN¥1.32 Billion | CN¥1.44 Billion | CN¥1.10 Billion | ▲ +7.8 pp |
| 2017 | 17.7% | CN¥194.21 Million | CN¥1.10 Billion | CN¥963.66 Million | CN¥769.45 Million | ▼ -3.5 pp |
| 2016 | 21.2% | CN¥216.17 Million | CN¥1.02 Billion | CN¥960.46 Million | CN¥744.29 Million | ▼ -6.7 pp |
| 2015 | 27.9% | CN¥277.17 Million | CN¥994.18 Million | CN¥997.20 Million | CN¥720.03 Million | ▲ +33.2 pp |
| 2014 | -5.3% | CN¥-39.18 Million | CN¥742.08 Million | CN¥879.87 Million | CN¥919.04 Million | — |